Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global ABSSSI Treatment Market Portraiture
2.1.1. Global ABSSSI Treatment Market, by Drug, 2016
2.1.2. Global ABSSSI Treatment Market, by Pathogen, 2016
2.1.3. Global ABSSSI Treatment Market, by Infection, 2016
2.1.4. Global ABSSSI Treatment Market, by Geography, 2016
Chapter 3. ABSSSI Treatment Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. ABSSSI: Epidemiology
3.3. ABSSSI Treatment: Future Trends
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2016
3.8. Major Agreements, Partnerships and Collaborations
3.9. Competitive Landscape
3.9.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global ABSSSI Treatment Market, by Drug
4.2. Delafloxacin
4.3. Vancomycin
4.4. Ceftaroline fosamil
4.5. Telvancin
4.6. Oritavancin
4.7. Tedizolid
4.8. Daptomycin
4.9. Tigecycline
4.10. Linezolid
4.11. TMP-SMZ
4.12. Others (Doxycycline, Levofloxacin, Metronidazole, and Others)
Chapter 5. Global ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global ABSSSI Treatment Market, by Infection
5.2. Cellulitis
5.3. Abscess/Boil/Cyst
5.4. Surgical Wound
5.5. Traumatic Wound
Chapter 6. Global ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global ABSSSI Treatment Market, by Pathogen
6.2. Methicillin sensitive Staphylococcus aureus (MSSA)
6.3. Methicillin resistant Staphylococcus aureus (MRSA)
6.4. Beta-hemolytic Streptococcus
6.5. Escherichia coli
6.6. Enterococcus faecalis
6.7. Pseudomonas aeruginosa
6.8. Others
Chapter 7. Global ABSSSI Treatment Market: Pipeline Analysis
7.1. Overview
7.2. Phase III (Market estimations by 2025)
7.2.1. Ceftobiprole (Basilea Pharmaceutica)
7.2.2. MK-1986 (Merck Sharp & Dohme Corp.)
7.2.3. TR-701 FA (Trius Therapeutics LLC)
7.3. Phase II (Qualitative Information)
7.4. Phase I (Qualitative Information)
7.5. Preclinical Studies (Qualitative Information)
Chapter 8. Global ABSSSI Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
8.1. Overview
8.2. North America ABSSSI Treatment Market Analysis, 2015 – 2025
8.2.1. North America ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
8.2.2. North America ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
8.2.3. North America ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
8.2.4. North America ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.2.4.1. U.S.
8.2.4.2. Canada
8.3. Europe ABSSSI Treatment Market Analysis, 2015 – 2025
8.3.1. Europe ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
8.3.2. Europe ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
8.3.3. Europe ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
8.3.4. Europe ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.3.4.1. U.K.
8.3.4.2. Germany
8.3.4.3. France
8.3.4.4. Spain
8.3.4.5. Italy
8.3.4.6. Rest of Europe
8.4. Asia Pacific ABSSSI Treatment Market Analysis, 2015 – 2025
8.4.1. Asia Pacific ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
8.4.2. Asia Pacific ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
8.4.3. Asia Pacific ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
8.4.4. Asia Pacific ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.4.4.1. Japan
8.4.4.2. China
8.4.4.3. India
8.4.4.4. Rest of APAC
8.5. Latin America ABSSSI Treatment Market Analysis, 2015 – 2025
8.5.1. Latin America ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
8.5.2. Latin America ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
8.5.3. Latin America ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
8.5.4. Latin America ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
8.5.4.1. Brazil
8.5.4.2. Mexico
8.5.4.3. Rest of Latin America
8.6. Middle East & Africa (MEA) ABSSSI Treatment Market Analysis, 2015 – 2025
8.6.1. MEA ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
8.6.2. MEA ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
8.6.3. MEA ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
8.6.4. MEA ABSSSI Treatment Market, by Region, 2015 – 2025 (US$ Mn)
8.6.4.1. UAE
8.6.4.2. Saudi Arabia
8.6.4.3. South Africa
8.6.4.4. Rest of MEA
Chapter 9. Company Profiles
9.1. Furiex Pharmaceuticals, Inc.
9.1.1. Business Description
9.1.2. Financial Information (Subject to data availability)
9.1.3. Product Portfolio
9.1.4. Key Developments
9.2. GlaxoSmithKline plc
9.3. Melinta Therapeutics, Inc.
9.4. Debiopharm International S.A.
9.5. MerLion Pharmaceuticals Pte Ltd.
9.6. Durata Therapeutics, Inc.
9.7. Paratek Pharmaceuticals, Inc.
9.8. Cempra, Inc.
9.9. Abbott Laboratories, Inc.
9.10. Actelion Pharmaceuticals Ltd.
9.11. Albany Molecular Research, Inc.
9.12. Allergan plc.
9.13. AstraZeneca
9.14. Bayer AG
9.15. Macrolide Pharmaceuticals, Inc.
9.16. Merck & Co, Inc.
9.17. Pfizer, Inc.
9.18. Sanofi
9.19. Teva Pharmaceuticals Industries Ltd.
9.20. Zavante Therapeutics, Inc.
List of Figures
FIG. 1 ABSSSI Treatment: Market Segmentation
FIG. 2 Global ABSSSI Treatment Market Share, by Drug, 2016 (Value %)
FIG. 3 Global ABSSSI Treatment Market, by Infection, 2016 (US$ Mn)
FIG. 4 Global ABSSSI Treatment Market, by Pathogen, 2016 (US$ Mn)
FIG. 5 Global ABSSSI Treatment Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography, 2016
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Delafloxacin Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Global Vancomycin Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Global Ceftaroline fosami Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Global Telvancin Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Global Oritavancin Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 13 Global Tedizolid Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 14 Global Daptomycin Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 15 Global Tigecycline Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 16 Global Linezolid Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 17 Global TMP-SMZ Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 18 Global Others Market in ABSSSI Treatment, 2015 – 2025 (US$ Mn)
FIG. 19 Global ABSSSI based Cellulitis Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global ABSSSI based Abscess/Boil/Cyst Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global ABSSSI based Surgical Wound Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 22 Global ABSSSI based Traumatic Wound Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 23 Global Methicillin sensitive Staphylococcus aureus (MSSA) Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 24 Global Methicillin resistant Staphylococcus aureus (MRSA) Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 25 Global Beta-hemolytic Streptococcus Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 26 Global Escherichia coli Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 27 Global Enterococcus faecalis Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 28 Global Pseudomonas aeruginosa Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 29 Global Other Pathogens Treatment Market in ABSSSI, 2015 – 2025 (US$ Mn)
FIG. 30 Global Ceftobiprole Market in ABSSSI Treatment (Forecast by 2025) (US$ Mn)
FIG. 31 Global MK-1986 Market in ABSSSI Treatment (Forecast by 2025) (US$ Mn)
FIG. 32 Global TR-701 FA Market in ABSSSI Treatment (Forecast by 2025) (US$ Mn)
FIG. 33 U.S. ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 34 Canada ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 35 U.K. ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 36 Germany ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 37 France ABSSSI Treatment Market, 2015-2025 (US$ Mn)
FIG. 38 Spain ABSSSI Treatment Market, 2015-2025 (US$ Mn)
FIG. 39 Italy ABSSSI Treatment Market, 2015-2025 (US$ Mn)
FIG. 40 Rest of Europe ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 41 Japan ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 42 China ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 43 India ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 44 Rest of Asia Pacific ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 45 Brazil ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 46 Mexico ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 47 Rest of Latin America ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 48 UAE ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 49 Saudi Arabia ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 50 South Africa ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 51 Rest of Middle East and Africa ABSSSI Treatment Market, 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
TABLE 2 Global ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
TABLE 3 Global ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
TABLE 4 Global ABSSSI Treatment Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
TABLE 6 North America ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
TABLE 7 North America ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
TABLE 8 North America ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
TABLE 10 Europe ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
TABLE 11 Europe ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
TABLE 12 Europe ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America ABSSSI Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa ABSSSI Treatment Market, by Drug, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa ABSSSI Treatment Market, by Infection, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa ABSSSI Treatment Market, by Pathogen, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa ABSSSI Treatment Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 25 Furiex Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Melinta Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Debiopharm International S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 MerLion Pharmaceuticals Pte Ltd..: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Durata Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Paratek Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Cempra, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Abbott Laboratories, Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Actelion Pharmaceuticals Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Albany Molecular Research, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 Allergan plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 AstraZeneca : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 39 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 40 Macrolide Pharmaceuticals, Inc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 41 Merck & Co, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 42 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 43 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 44 Teva Pharmaceuticals Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 45 Zavante Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)